UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002383
Receipt number R000002925
Scientific Title Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer
Date of disclosure of the study information 2009/08/25
Last modified on 2013/03/25 16:42:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer

Acronym

Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer

Scientific Title

Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer

Scientific Title:Acronym

Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer

Region

Japan


Condition

Condition

non-small-cell lung cancer

Classification by specialty

Medicine in general Pneumology Hematology and clinical oncology
Surgery in general Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Feasibility study

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The percentage of patients who accomplished S-1 therapy of eight courses.

Key secondary outcomes

Adverse events
The relative total administration dose of S-1


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Adjuvant chemotherapy of eight courses
(2-week administration and 1-week withdrawal): S-1 dose of 67mg/m2 twice daily

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

70 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Histologically confirmed NSCLC
2)p-Stage IB, II and III & complete resection
3)No prior treatment
4)Adjuvant chemotherapy within 4-8 weeks
5)ECOG PS 0-1
6)Age 70 or older
7)Adequate organ function
8)Written informed consent

Key exclusion criteria

1)Past history of drug hypersensitivity
2)Past history of myocardial infarction within 6 months
3)Interstitial pneumonia or active lung fibrosis
4)Uncontrolled heart diseases
5)Uncontrolled psychiatric disorders
6)Uncontrolled diabetes
7)Bowel problems
8)Active infection
9)Severe complications
10)Active concomitant malignancy

Target sample size

25


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yukito Ichinose

Organization

National Kyushu Cancer Center

Division name

Department of Thoracic Oncology

Zip code


Address

Fukuoka

TEL

092-541-3231

Email



Public contact

Name of contact person

1st name
Middle name
Last name Noriyuki Ebi

Organization

Iizuka Hospital

Division name

Department of respiratory medicine

Zip code


Address


TEL

0948-22-3800

Homepage URL


Email



Sponsor or person

Institute

Lung Oncology Group in Kyushu, Japan (LOGIK)

Institute

Department

Personal name



Funding Source

Organization

Clinical Research Support Center kyushu

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

飯塚病院(福岡県)、新日鐵八幡記念病院(福岡県)、大分県立病院(大分県)、熊本地域医療センター(熊本県)、長崎大学病院(長崎県)、浜の町病院(福岡県)、国立病院機構大牟田病院(福岡県)、九州大学(福岡県)、熊本大学(熊本県)


Other administrative information

Date of disclosure of the study information

2009 Year 08 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 03 Month 20 Day

Date of IRB


Anticipated trial start date

2009 Year 04 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 08 Month 25 Day

Last modified on

2013 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002925


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name